{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:57:18Z","timestamp":1788991038108,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Diputaci\u00f3 de Lleida and the Generalitat de Catalunya","award":["2017SGR696"],"award-info":[{"award-number":["2017SGR696"]}]},{"name":"Diputaci\u00f3 de Lleida and the Generalitat de Catalunya","award":["SLT0021600250"],"award-info":[{"award-number":["SLT0021600250"]}]},{"name":"Menarini Spain S.A"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Prediabetes has recently been associated with subclinical atheromatous disease in the middle-aged population. Our aim was to characterize atheromatous plaque burden by the number of affected territories and the total plaque area in the prediabetes stage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Atheromatous plaque burden (quantity of plaques and total plaque area) was assessed in 12 territories from the carotid and femoral regions using ultrasonography in 6688 non-diabetic middle-aged subjects without cardiovascular disease. Prediabetes was defined by glycosylated hemoglobin (HbA1c) between 5.7 and 6.4% according to the American Diabetes Association guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Prediabetes was diagnosed in 33.9% (n\u2009=\u20092269) of the ILERVAS participants. Subjects with prediabetes presented a higher prevalence of subclinical atheromatous disease than participants with HbA1c\u2009&lt;\u20095.7% (70.4 vs. 67.5%, p\u2009=\u20090.017). In the population with prediabetes this was observed at the level of the carotid territory (p\u2009&lt;\u20090.001), but not in the femoral arteries. Participants in the prediabetes stage also presented a significantly higher number of affected territories (2 [1;3] vs. 1 [0;3], p\u2009=\u20090.002), with a positive correlation between HbA1c levels and the number of affected territories (r\u2009=\u20090.068, p\u2009&lt;\u20090.001). However, atheromatosis was only significantly (p\u2009=\u20090.016) magnified by prediabetes in those subjects with 3 or more cardiovascular risk factors. The multivariable logistic regression model showed that the well-established cardiovascular risk factors together with HbA1c were independently associated with the presence of atheromatous disease in participants with prediabetes. When males and females were analyzed separately, we found that only men with prediabetes presented both carotid and femoral atherosclerosis, as well as an increase of total plaque area in comparison with non-prediabetic subjects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The prediabetes stage is accompanied by an increased subclinical atheromatous disease only in the presence of other cardiovascular risk factors. Prediabetes modulates the atherogenic effect of cardiovascular risk factors in terms of distribution and total plaque area in a sex-dependent manner.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> NCT03228459 (clinicaltrials.gov)<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-019-0962-6","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T11:03:03Z","timestamp":1573815783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Characteristics of atheromatosis in the prediabetes stage: a cross-sectional investigation of the ILERVAS project"],"prefix":"10.1186","volume":"18","clinical-trial-number":[{"clinical-trial-number":"nct03228459","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Enric","family":"S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c0ngels","family":"Betriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"L\u00f3pez-Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Purroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelino","family":"Berm\u00fadez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Farr\u00e0s-Sall\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Barril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinald","family":"Pamplona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Rius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Sim\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-0183","authenticated-orcid":false,"given":"Albert","family":"Lecube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the ILERVAS project collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Barb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Manuel","family":"Valdivielso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gl\u00f2ria","family":"Arqu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Vena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ortega-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seraf\u00edn","family":"Cambray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Portero-Otin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Jov\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Mart\u00ednez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"962_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381.","journal-title":"Diabetes Res Clin Pract"},{"key":"962_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2337\/dci18-0007","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. Economic costs of diabetes in the US in 2017. Diabetes Care. 2018;41:917\u201328.","journal-title":"Diabetes Care"},{"key":"962_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jval.2017.12.019","volume":"21","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Economic burden of cardiovascular disease in type 2 diabetes: a systematic review. Value Health. 2018;21:881\u201390.","journal-title":"Value Health"},{"key":"962_CR4","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/S0021-9150(97)00314-6","volume":"137","author":"M Laakso","year":"1998","unstructured":"Laakso M, Lehto S. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. Atherosclerosis. 1998;137:S65\u201373.","journal-title":"Atherosclerosis"},{"key":"962_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1161\/ATVBAHA.116.306256","volume":"37","author":"K Yahagi","year":"2017","unstructured":"Yahagi K, Kolodgie FD, Lutter C, Mori H, Romero ME, Finn AV, Virmani R. Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus. Arterioscler Thromb Vasc Biol. 2017;37:191\u2013204.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"962_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12933-018-0788-7","volume":"17","author":"G Schernthaner","year":"2018","unstructured":"Schernthaner G, Lotan C, Baltadzhieva-Trendafilova E, Ceponis J, Clodi M, Ducena K, Goncalvesova E, Guja C, Honka M, Jane\u017e A, Lali\u0107 N, Lehmann R, Nyolczas N, Pauklin P, Rynkiewicz A, Sergienko I, Duvnjak LS. Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier? Cardiovasc Diabetol. 2018;17:145.","journal-title":"Cardiovasc Diabetol."},{"key":"962_CR7","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.2337\/dc11-2403","volume":"35","author":"JS Rana","year":"2012","unstructured":"Rana JS, Dunning A, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng VY, Chinnaiyan K, Chow BJ, Cury R, Delago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann P, Karlsberg RP, Kim YJ, Leipsic J, Labounty TM, Lin FY, Maffei E, Raff G, Villines TC, Shaw LJ, Berman DS, Min JK. Differences in prevalence, extent, severity, and prognosis of coronary artery disease among patients with and without diabetes undergoing coronary computed tomography angiography: results from 10,110 individuals from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes): an InteRnational Multicenter Registry. Diabetes Care. 2012;35:1787\u201394.","journal-title":"Diabetes Care"},{"key":"962_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s12020-014-0436-2","volume":"48","author":"M Buysschaert","year":"2015","unstructured":"Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. Prediabetes and associated disorders. Endocrine. 2015;48:371\u201393.","journal-title":"Endocrine"},{"key":"962_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIRCRESAHA.118.311912","volume":"122","author":"DH Wasserman","year":"2018","unstructured":"Wasserman DH, Wang TJ, Brown NJ. The vasculature in prediabetes. Circ Res. 2018;122:1135\u201350.","journal-title":"Circ Res"},{"key":"962_CR10","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.metabol.2014.08.008","volume":"63","author":"SF Burns","year":"2014","unstructured":"Burns SF, Lee S, Bacha F, Tfayli H, Hannon TS, Arslanian SA. Pre-diabetes in overweight youth and early atherogenic risk. Metabolism. 2014;63:1528\u201335.","journal-title":"Metabolism."},{"key":"962_CR11","doi-asserted-by":"publisher","first-page":"i5953","DOI":"10.1136\/bmj.i5953","volume":"355","author":"Y Huang","year":"2016","unstructured":"Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953.","journal-title":"BMJ"},{"key":"962_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12933-018-0694-z","volume":"17","author":"G Lee","year":"2018","unstructured":"Lee G, Kim SM, Choi S, Kim K, Jeong SM, Son JS, Yun JM, Park SM. The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study. Cardiovasc Diabetol. 2018;17:51.","journal-title":"Cardiovasc Diabetol."},{"key":"962_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.nefro.2016.02.008","volume":"36","author":"\u00c0 Betriu","year":"2016","unstructured":"Betriu \u00c0, Farr\u00e0s C, Abajo M, Martinez-Alonso M, Arroyo D, Barb\u00e9 F, Buti M, Lecube A, Portero M, Purroy F, Torres G, Valdivielso JM, Fern\u00e1ndez E. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: the ILERVAS project. Nefrologia. 2016;36:389\u201396.","journal-title":"Nefrologia."},{"key":"962_CR14","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc17-S005","volume":"40","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes. Sec. 2. In standards of medical care in diabetes\u20142017. Diabetes Care. 2017;40:S11\u201324.","journal-title":"Diabetes Care"},{"key":"962_CR15","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1373\/clinchem.2014.224311","volume":"60","author":"E Lenters-Westra","year":"2014","unstructured":"Lenters-Westra E, Slingerland RJ. Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria. Clin Chem. 2014;60:1062\u201372.","journal-title":"Clin Chem"},{"key":"962_CR16","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1161\/01.STR.31.9.2189","volume":"31","author":"MM Sabetai","year":"2000","unstructured":"Sabetai MM, Tegos TJ, Nicolaides AN, Dhanjil S, Pare GJ, Stevens JM. Reproducibility of computer-quantified carotid plaque echogenicity: can we overcome the subjectivity? Stroke. 2000;31:2189\u201396.","journal-title":"Stroke"},{"key":"962_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000081812","volume":"18","author":"PJ Touboul","year":"2004","unstructured":"Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Kownator S, Prati P, Rundek T, Taylor A, Bornstein N, Csiba L, Vicaut E, Woo KS, Zannad F. Advisory board of the 3rd watching the risk symposium 2004, 13th European stroke conference. Mannheim intima-media thickness consensus. Cerebrovasc Dis. 2004;18:346\u20139.","journal-title":"Cerebrovasc Dis"},{"key":"962_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","volume":"21","author":"JH Stein","year":"2008","unstructured":"Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS, American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American society of echocardiography carotid intima-media thickness task force endorsed by the society for vascular medicine. J Am Soc Echocardiogr. 2008;21:93\u2013111.","journal-title":"J Am Soc Echocardiogr."},{"key":"962_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2014.09.002","volume":"237","author":"E Tiozzo","year":"2014","unstructured":"Tiozzo E, Gardener H, Hudson BI, Dong C, Della-Morte D, Crisby M, Goldberg RB, Elkind MS, Cheung YK, Wright CB, Sacco RL, Rundek T. High-density lipoprotein subfractions and carotid plaque: the Northern Manhattan Study. Atherosclerosis. 2014;237:163\u20138.","journal-title":"Atherosclerosis"},{"key":"962_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00125-008-1173-y","volume":"52","author":"S Moebus","year":"2009","unstructured":"Moebus S, Stang A, M\u00f6hlenkamp S, Dragano N, Schmermund A, Slomiany U, Hoffmann B, Bauer M, Broecker-Preuss M, Mann K, Siegrist J, Erbel R, J\u00f6ckel KH, Heinz Nixdorf Recall Study Group. Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort\u2014results of the Heinz Nixdorf Recall Study. Diabetologia. 2009;52:81\u20139.","journal-title":"Diabetologia"},{"key":"962_CR21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.2337\/dc09-0074","volume":"32","author":"MJ McNeely","year":"2009","unstructured":"McNeely MJ, McClelland RL, Bild DE, Jacobs DR Jr, Tracy RP, Cushman M, Goff DC Jr, Astor BC, Shea S, Siscovick DS. The association between A1C and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis. Diabetes Care. 2009;32:1727\u201333.","journal-title":"Diabetes Care"},{"key":"962_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ijcard.2017.05.073","volume":"243","author":"GM Park","year":"2017","unstructured":"Park GM, Cho YR, Lee SW, Yun SC, Won KB, Ann SH, Kim YG, Kim SJ, Roh JH, Kim YH, Yang DH, Kang JW, Lim TH, Jung CH, Koh EH, Lee WJ, Kim MS, Lee KU, Park JY, Kim HK, Choe J, Lee SG. Prediabetes is not a risk factor for subclinical coronary atherosclerosis. Int J Cardiol. 2017;243:479\u201384.","journal-title":"Int J Cardiol"},{"key":"962_CR23","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2337\/dc17-2233","volume":"41","author":"JP Reis","year":"2018","unstructured":"Reis JP, Allen NB, Bancks MP, Carr JJ, Lewis CE, Lima JA, Rana JS, Gidding SS, Schreiner PJ. Duration of diabetes and prediabetes during adulthood and subclinical atherosclerosis and cardiac dysfunction in middle age: the CARDIA study. Diabetes Care. 2018;41:731\u20138.","journal-title":"Diabetes Care"},{"key":"962_CR24","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.2337\/db06-0319","volume":"55","author":"G Bock","year":"2006","unstructured":"Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Rizza R. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and\/or impaired glucose tolerance. Diabetes. 2006;55:3536\u201349.","journal-title":"Diabetes"},{"key":"962_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jacc.2007.09.038","volume":"51","author":"YS Levitzky","year":"2008","unstructured":"Levitzky YS, Pencina MJ, D\u2019Agostino RB, Meigs JB, Murabito JM, Vasan RS, Fox CS. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol. 2008;51:264\u201370.","journal-title":"J Am Coll Cardiol"},{"key":"962_CR26","doi-asserted-by":"publisher","first-page":"448","DOI":"10.21037\/atm.2018.11.18","volume":"6","author":"PY Scarabin","year":"2018","unstructured":"Scarabin PY. Endogenous sex hormones and cardiovascular disease in postmenopausal women: new but conflicting data. Ann Transl Med. 2018;6:448.","journal-title":"Ann Transl Med"},{"key":"962_CR27","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1210\/jc.2014-3934","volume":"100","author":"R Srinath","year":"2015","unstructured":"Srinath R, Hill Golden S, Carson KA, Dobs A. Endogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the atherosclerosis risk in communities study. J Clin Endocrinol Metab. 2015;100:1602\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"962_CR28","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1161\/STROKEAHA.107.486480","volume":"38","author":"S Dalager","year":"2007","unstructured":"Dalager S, Paaske WP, Kristensen IB, Laurberg JM, Falk E. Artery-related differences in atherosclerosis expression: implications for atherogenesis and dynamics in intima-media thickness. Stroke. 2007;38:2698\u2013705.","journal-title":"Stroke"},{"key":"962_CR29","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10554-015-0737-4","volume":"31","author":"A Helck","year":"2015","unstructured":"Helck A, Bianda N, Canton G, Yuan C, Hippe DS, Reiser MF, Gallino A, Wyttenbach R, Saam T. Intra-individual comparison of carotid and femoral atherosclerotic plaque features with in vivo MR plaque imaging. Int J Cardiovasc Imaging. 2015;31:1611\u20138.","journal-title":"Int J Cardiovasc Imaging"},{"key":"962_CR30","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/01.STR.28.6.1189","volume":"28","author":"J Hulthe","year":"1997","unstructured":"Hulthe J, Wikstrand J, Emanuelsson H, Wiklund O, de Feyter PJ, Wendelhag I. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke. 1997;28:1189\u201394.","journal-title":"Stroke"},{"key":"962_CR31","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3109\/07853890.2014.955051","volume":"46","author":"Y Huang","year":"2014","unstructured":"Huang Y, Cai X, Chen P, Mai W, Tang H, Huang Y, Hu Y. Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med. 2014;46:684\u201392.","journal-title":"Ann Med"},{"key":"962_CR32","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215\u201322.","journal-title":"Lancet"},{"key":"962_CR33","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/archneurol.2011.146","volume":"68","author":"A Callahan","year":"2011","unstructured":"Callahan A, Amarenco P, Goldstein LB, Sillesen H, Messig M, Samsa GP, Altafullah I, Ledbetter LY, MacLeod MJ, Scott R, Hennerici M, Zivin JA, Welch KM, SPARCL Investigators. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Arch Neurol. 2011;68:1245\u201351.","journal-title":"Arch Neurol"},{"key":"962_CR34","doi-asserted-by":"publisher","first-page":"e3564","DOI":"10.1136\/bmj.e3564","volume":"344","author":"M Lee","year":"2012","unstructured":"Lee M, Saver JL, Hong KS, Song S, Chang KH, Ovbiagele B. Effect of pre-diabetes on future risk of stroke: meta-analysis. Br Med J. 2012;344:e3564.","journal-title":"Br Med J"},{"key":"962_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S2213-8587(13)70175-X","volume":"2","author":"E Ferrannini","year":"2014","unstructured":"Ferrannini E. Definition of intervention points in prediabetes. Lancet Diabetes Endocrinol. 2014;2:667\u201375.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"962_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2337\/dc06-1392","volume":"30","author":"GA Nichols","year":"2007","unstructured":"Nichols GA, Hillier TA, Brown JB. Progression from newly acquired impaired fasting glusose to type 2 diabetes. Diabetes Care. 2007;30:228\u201333.","journal-title":"Diabetes Care"},{"key":"962_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/STROKEAHA.109.566596","volume":"41","author":"JF Polak","year":"2010","unstructured":"Polak JF, Person SD, Wei GS, Godreau A, Jacobs DR Jr, Harrington A, Sidney S, O\u2019Leary DH. Segment-specific associations of carotid intima-media thickness with cardiovascular risk factors: the coronary artery risk development in young adults (CARDIA) study. Stroke. 2010;41:9\u201315.","journal-title":"Stroke"},{"key":"962_CR38","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1161\/01.RES.53.4.502","volume":"53","author":"CK Zarins","year":"1983","unstructured":"Zarins CK, Giddens DP, Bharadvaj BK, Sottiurai VS, Mabon RF, Glagov S. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res. 1983;53:502\u201314.","journal-title":"Circ Res"},{"key":"962_CR39","first-page":"909","volume":"97","author":"J Janzen","year":"2004","unstructured":"Janzen J. The microscopic transitional zone between elastic and muscular arteries. Arch Mal Coeur Vaiss. 2004;97:909\u201314.","journal-title":"Arch Mal Coeur Vaiss"},{"key":"962_CR40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/eurheartj\/ehr332","volume":"33","author":"N Bianda","year":"2012","unstructured":"Bianda N, Di Valentino M, P\u00e9riat D, Segatto JM, Oberson M, Moccetti M, Sudano I, Santini P, Limoni C, Froio A, Stuber M, Corti R, Gallino A, Wyttenbach R. Progression of human carotid and femoral atherosclerosis: a prospective follow-up study by magnetic resonance vessel wall imaging. Eur Heart J. 2012;33:230\u20137.","journal-title":"Eur Heart J"},{"key":"962_CR41","first-page":"437","volume":"34","author":"AG Panayiotou","year":"2015","unstructured":"Panayiotou AG, Kouis P, Griffin M, Nicolaides AN. Comparison between insulin resistance indices and carotid and femoral atherosclerosis: a cross-sectional population study. Int Angiol. 2015;34:437\u201344.","journal-title":"Int Angiol"},{"key":"962_CR42","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.jacl.2016.07.001","volume":"10","author":"A Di Pino","year":"2016","unstructured":"Di Pino A, Currenti W, Urbano F, Mantegna C, Purrazzo G, Piro S, Purrello F, Rabuazzo AM. Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects. J Clin Lipidol. 2016;10:1098\u2013108.","journal-title":"J Clin Lipidol"},{"key":"962_CR43","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jjcc.2016.08.006","volume":"69","author":"C Altin","year":"2017","unstructured":"Altin C, Sade LE, Gezmis E, Yilmaz M, Ozen N, Muderrisoglu H. Assessment of epicardial adipose tissue and carotid\/femoral intima media thickness in insulin resistance. J Cardiol. 2017;69:843\u201350.","journal-title":"J Cardiol"},{"key":"962_CR44","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1136\/hrt.2009.188219","volume":"96","author":"S Chaubey","year":"2010","unstructured":"Chaubey S, Nitsch D, Altmann D, Ebrahim S. Differing effect of modifiable cardiovascular risk factors on intima-media thickening and plaque formation at different sites of the arterial vasculature. Heart. 2010;96:1579\u201385.","journal-title":"Heart"},{"key":"962_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.diabres.2010.06.008","volume":"90","author":"SA Mostafa","year":"2010","unstructured":"Mostafa SA, Khunti K, Srinivasan BT, Webb D, Gray LJ, Davies MJ. The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort. Diabetes Res Clin Pract. 2010;90:100\u20138.","journal-title":"Diabetes Res Clin Pract"},{"key":"962_CR46","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1210\/jc.2012-3185","volume":"98","author":"C Lorenzo","year":"2013","unstructured":"Lorenzo C, Hartnett S, Hanley AJ, Rewers MJ, Wagenknecht LE, Karter AJ, Haffner SM. Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study. J Clin Endocrinol Metab. 2013;98:1622\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"962_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S2213-8587(16)30321-7","volume":"5","author":"B Warren","year":"2017","unstructured":"Warren B, Pankow JS, Matsushita K, Punjabi NM, Daya NR, Grams M, Woodward M, Selvin E. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the atherosclerosis risk in communities (ARIC) study. Lancet Diabetes Endocrinol. 2017;5:34\u201342.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"962_CR48","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task force on clinical practice guidelines. J Am Coll Cardiol. 2019;73:e285\u2013350.","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0962-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-019-0962-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0962-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:17:12Z","timestamp":1628612232000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-019-0962-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["962"],"URL":"https:\/\/doi.org\/10.1186\/s12933-019-0962-6","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"assertion":[{"value":"5 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all the ILERVAS participants. The protocol was approved by the Arnau de Vilanova University Hospital ethics committee (CEIC-1410). The study was conducted according to the ethical guidelines of the Helsinki Declaration and Spanish legislation regarding the protection of personal information was also followed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}